Trial Profile
Soft tissue changes induced by Repeated Serial Intra-Articular Etanercept Injections in the knee joints of patients with Resistant Knee Joint Synovitis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2009
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis; Synovitis
- Focus Pharmacodynamics
- 10 Sep 2009 New trial record.